Skip to main content
. 2021 Jan 11;11:350. doi: 10.1038/s41598-020-79798-7

Table 5.

Basic and clinical characteristics of desaturated patients.

Age Gender BMI
(kg/m2)
ASA class Indication for ERCP Procedure time (min) Type and dose of sedative Accompanying symptom Treatment
84 Female 24.9 III CBD Stone 6

Midazolam

(5 mg)

Agitation Flumazenil
84 Male 21.1 I CBD Stone 32

Midazolam

(10 mg)

Agitation Flumazenil
88 Female 22.6 II CBD Stone 6

Midazolam

(10 mg)

Bradycardia Flumazenil
92 Female 18.2 I CBD Stone 27

Midazolam

(5 mg)

Tachycardia

Flumazenil

HFNO 0.7/50

89 Male 28.4 II CBD Stone 25

Midazolam

(5 mg)

Agitation

Flumazenil

HFNO 0.6/50

79 Female 16.9 II CBD Stone 12

Midazolam plus Propofol

(5 mg plus

30 mg)

Agitation

Flumazenil

HFNO 0.7/50

59 Male 26.6 II CBD Stone 13 Propofol (240 mg) Agitation

HFNO 0.7/50,

Stop ERCP

82 Male 18.7 I CBD Stone 13

Midazolam

(5 mg)

Agitation

Flumazenil

HFNO 0.7/50

82 Male 18.5 III CBD Stone 3

Midazolam

(5 mg)

Agitation

Flumazenil

HFNO 0.7/50

BMI, body mass index; HTN, hypertension; DM, diabetes mellitus; CAOD, coronary artery obstructive disease; MI, myocardial infarction; CHF, congestive heart failure; ASA, the American Society of Anesthesiologists; CBD, common bile duct; HFNO, high flow nasal oxygen.